当代急性冠脉综合征临床试验中老年患者、女性及少数族裔的入组情况:系统综述
结果显示试验参与者平均年龄62.9岁、女性占26.8%,均低于流行病学研究中的相应人群;仅21.5%试验报告种族数据,黑人患者占3.7%且无改善。
要点
- ACS试验中老年和女性患者比例低于流行病学研究,代表性不足。
- 仅21.5%试验报告种族数据,黑人患者占比低且随时间无改善。
- 试验参与者平均年龄随时间轻度增加,但女性比例无显著改善。
核心结论
- 与流行病学研究相比,当代ACS试验中老年患者和女性代表性不足;老年患者代表性略有改善,女性无改善。
- 超过四分之三的试验未报告种族数据,已有数据显示非白人入组略有增加,主要因亚裔和西班牙裔增加,黑人患者入组持续偏低。
研究设计与样本
- 将试验中年龄、性别和种族分布与ACS流行病学研究进行比较。
主要发现
- 美国流行病学研究中平均(SD)年龄为66.4(14.8)岁,欧洲为70.0(13.5)岁。
- 美国流行病学研究中女性加权比例为38.0%,欧洲为32.0%。
- 仅99项试验(21.5%)报告种族分布;报告数据的试验中非白人占15.0%,从2001-2006年的12.0%增至2013-2018年的14.0%。
关键数值与推荐
- 黑人患者占全部患者的3.7%,亚裔占9.6%,西班牙裔占7.8%。
- 黑人患者比例从2001-2006年的5.2%至2013-2018年的4.9%无变化;亚裔从1.9%增至10.8%,西班牙裔从5.4%增至14.5%。
临床怎么用
- 解读ACS试验结果时需注意老年、女性及少数族裔患者代表性不足,外推至这些人群应谨慎。
- 关注试验报告人群特征与真实世界ACS人群的差异,个体化评估证据适用性。
局限性
- 仅纳入8种主要医学期刊的试验,可能遗漏其他期刊数据。
- 种族/族裔数据报告率低(仅21.5%试验),限制相关趋势分析。
- 与流行病学研究的比较为描述性,未进行统计校正。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Although age, sex, and race/ethnicity are important factors when generalizing the findings of clinical trials to routine practice, trends in the representation of these groups in contemporary acute coronary syndrome (ACS) trials are not well defined. OBJECTIVE: To characterize the representation of older patients, women, and racial/ ethnic minorities in ACS randomized trials. EVIDENCE REVIEW: A systemic search was conducted of ACS trials published in 8 major medical journals between January 2001 and December 2018. Overall, 1 067 520 patients from 460 trials were included. Findings were compared with epidemiologic studies of patients with ACS. FINDINGS: The median number of participants per trial was 711 (interquartile range, 324-2163) and the median number of sites per trial was 21 (interquartile range, 5-73). Overall, 207 trials (45.0%) studied drug therapy, and 210 (45.7%) evaluated procedural interventions. The mean (SD) age of trial participants was 62.9 (10.7) years and increased from 62.3 (11.2) years in 2001-2006 to 64.0 (10.4) years in 2013-2018 (P = .01). The corresponding mean (SD) age was 66.4 (14.8) years in US epidemiologic studies and 70.0 (13.5) years in European epidemiologic studies. The overall proportion of women enrolled was 26.8% and decreased over time, from 27.8% in 2001-2006 to 24.9% in 2013-2018 (P = .21 for trend). The corresponding weighted proportions of women were 38.0% in US epidemiologic studies and 32.0% in European studies. The distribution of racial/ethnic groups was reported in only 99 trials (21.5%). In trials with reported data, 15.0% of the trial participants were nonwhite, which increased from 12.0% in 2001-2006 to 14.0% in 2013-2018. Black patients represented 3.7% of all patients during the entire study time frame, Asian patients represented 9.6%, and Hispanic patients represented 7.8%. Trends in the representation of black patients remained unchanged from 2001-2006 (5.2%) to 2013-2018 (4.9%), while the enrollment of Asian and Hispanic patients increased from 2001-2006 to 2013-2018 (from 1.9% to 10.8% for Asian patients and from 5.4% to 14.5% for Hispanic patients). CONCLUSIONS AND RELEVANCE: Older patients and women are underrepresented in contemporary ACS trials compared with epidemiologic studies. Over time, there has been modest improvement in the representation of older patients but not women patients. More than three-quarters of trials did not report race/ethnicity data, with available data suggesting a modest increase in the enrollment of nonwhite patients owing to the enrollment of Asian and Hispanic patients. Enrollment of black patients remained low over time.
引用
- Tahhan AS, Vaduganathan M, Greene SJ, et al. Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review. JAMA Cardiol. 2020. PMID: 32211813. doi:10.1001/jamacardio.2020.0359
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。